93 related articles for article (PubMed ID: 32239101)
41. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma].
Xu Q; Cai W; Zhang M; Liu Q; Liu X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):387-92. PubMed ID: 26927562
[TBL] [Abstract][Full Text] [Related]
42. Clinicopathologic Significance of Quaking Expression in Hepatocellular Carcinoma.
Kim SE; Park CK; Park JW; Lee JW; Choe JY; Cho YA
In Vivo; 2024; 38(4):2064-2073. PubMed ID: 38936929
[TBL] [Abstract][Full Text] [Related]
43. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
[TBL] [Abstract][Full Text] [Related]
44. GABPA predicts prognosis and inhibits metastasis of hepatocellular carcinoma.
Zhang S; Zhang K; Ji P; Zheng X; Jin J; Feng M; Liu P
BMC Cancer; 2017 May; 17(1):380. PubMed ID: 28549418
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA-219-5p Promotes Tumor Growth and Metastasis of Hepatocellular Carcinoma by Regulating Cadherin 1.
Yang J; Sheng YY; Wei JW; Gao XM; Zhu Y; Jia HL; Dong QZ; Qin LX
Biomed Res Int; 2018; 2018():4793971. PubMed ID: 29862272
[TBL] [Abstract][Full Text] [Related]
46. Loss of N-cadherin is associated with loss of E-cadherin expression and poor outcomes of liver resection in hepatocellular carcinoma.
Liu YA; Liang BY; Guan Y; You J; Zhu L; Chen XP; Huang ZY
J Surg Res; 2015 Mar; 194(1):167-76. PubMed ID: 25438959
[TBL] [Abstract][Full Text] [Related]
47. Expression of HnRNP A1, ZEB1, and E-cadherin in Hepatocellular carcinoma and their impact on patients' prognosis and survival.
Abouhashem NS; Elwan A; El Hefnawy AS; Atwa HA
Indian J Pathol Microbiol; 2022; 65(3):589-597. PubMed ID: 35900486
[TBL] [Abstract][Full Text] [Related]
48. Metastasin leads to poor prognosis of hepatocellular carcinoma through partly inducing EMT.
Zheng X; Gai X; Wu Z; Liu Q; Yao Y
Oncol Rep; 2013 May; 29(5):1811-8. PubMed ID: 23483190
[TBL] [Abstract][Full Text] [Related]
49. Intratumoral and peritumoral expression of CD68 and CD206 in hepatocellular carcinoma and their prognostic value.
Ren CX; Leng RX; Fan YG; Pan HF; Li BZ; Wu CH; Wu Q; Wang NN; Xiong QR; Geng XP; Ye DQ
Oncol Rep; 2017 Aug; 38(2):886-898. PubMed ID: 28656201
[TBL] [Abstract][Full Text] [Related]
50. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
51. Prognostic implications of ezrin expression in human hepatocellular carcinoma.
Kang YK; Hong SW; Lee H; Kim WH
Mol Carcinog; 2010 Sep; 49(9):798-804. PubMed ID: 20572160
[TBL] [Abstract][Full Text] [Related]
52. [Correlation between androgen receptor expression and hepatitis B virus X protein and its clinical significance in hepatocellular carcinoma].
Gu DH; Zhu YZ; Wang X; Bai ZC; Ping JL; Chen Q; Zhu R
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):282-7. PubMed ID: 23985257
[TBL] [Abstract][Full Text] [Related]
53. Increased expression of EphA2 and E-N cadherin switch in primary hepatocellular carcinoma.
Fan M; Liu Y; Xia F; Wang Z; Huang Y; Li J; Wang Z; Li X
Tumori; 2013; 99(6):689-96. PubMed ID: 24503792
[TBL] [Abstract][Full Text] [Related]
54. Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma.
Dai XM; Huang T; Yang SL; Zheng XM; Chen GG; Zhang T
Dis Markers; 2017; 2017():8495326. PubMed ID: 28572700
[TBL] [Abstract][Full Text] [Related]
55. RARγ-induced E-cadherin downregulation promotes hepatocellular carcinoma invasion and metastasis.
Gan WJ; Wang JR; Zhu XL; He XS; Guo PD; Zhang S; Li XM; Li JM; Wu H
J Exp Clin Cancer Res; 2016 Oct; 35(1):164. PubMed ID: 27756432
[TBL] [Abstract][Full Text] [Related]
56. Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa.
Herath NI; Walsh MD; Kew MC; Young J; Leggett BA; Macdonald GA
J Gastroenterol Hepatol; 2004 Jun; 19(6):676-82. PubMed ID: 15151624
[TBL] [Abstract][Full Text] [Related]
57. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
58. Downregulation of MAGI1 associates with poor prognosis of hepatocellular carcinoma.
Zhang G; Liu T; Wang Z
J Invest Surg; 2012 Apr; 25(2):93-9. PubMed ID: 21942217
[TBL] [Abstract][Full Text] [Related]
59. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.
Hsu HC; Jeng YM; Mao TL; Chu JS; Lai PL; Peng SY
Am J Pathol; 2000 Sep; 157(3):763-70. PubMed ID: 10980116
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of PRL-3 expression, and its correlation with angiogenesis and invasion in hepatocellular carcinoma.
Zhao WB; Li Y; Liu X; Zhang LY; Wang X
Int J Mol Med; 2008 Aug; 22(2):187-92. PubMed ID: 18636172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
